• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT ACT CELITE CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT ACT CELITE CARTRIDGE Back to Search Results
Catalog Number 03P87-25
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/23/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Apoc incident#: (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
 
Event or Problem Description
On (b)(6) 2023, abbott point of care was contacted by a customer regarding act kaolin cartridges that yielded a discrepant result of >1000 on a 75 year female patient during a procedure.There was no additional information available at the time of this report.Return product is not available for investigation.Method date tested act (sec).I-stat on (b)(6) 2022 13:58 173, i-stat on (b)(6) 2022 14:12 144, i-stat on (b)(6) 2022 14:18 155, i-stat on (b)(6) 2022 14:39 >1000.Per i-stat system manual (art: 770715-00a), the i-stat kaolin activated clotting time (kaolinact) test is an in vitro diagnostic test that uses fresh, whole blood, and is used to monitor high-dose heparin anticoagulation frequently associated with cardiovascular surgery.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on the limited information that suggests the product was not performing within the variability of the assay.The customer alleges a falsely depressed result of 155 seconds after dosing the patient with no increase.Following an extra bolus, the act went too high and resulted in >1000 seconds.There were no details/times presented for heparin and limited patient information.It is suspected that the patient may be heparin resistant.An investigation is underway.
 
Event or Problem Description
Na.
 
Additional Manufacturer Narrative
Apoc incident: # (b)(4).The investigation was completed on 28-feb-2023.A review of the device history record (dhr) confirmed the cartridge lot passed release specifications.Retained cartridge testing met the acceptance criteria in appendix 1 of q04.01.003 rev.Ak (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT ACT CELITE CARTRIDGE
Common Device Name
ACT CELITE CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
Manufacturer (Section G)
ABBOTT POINT OF CARE CANADA LTD.
185 corkstown road
ottawa, ontario K2H 8 V4
CA   K2H 8V4
Manufacturer Contact
linda maczuszenko
400 college road
princeton, NJ 08540
6136885949
MDR Report Key16137496
Report Number2245578-2023-00004
Device Sequence Number15137640
Product Code JBP
UDI-Device Identifier10054749000156
UDI-Public10054749000156
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
K023582
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2023
Device Catalogue Number03P87-25
Device Lot NumberR22216
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 01/03/2023
Supplement Date Received by Manufacturer02/28/2023
Initial Report FDA Received Date01/11/2023
Supplement Report FDA Received Date03/01/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/04/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age75 YR
Patient SexFemale
-
-